Rationale And Objectives: The magnitude of iron-induced susceptibility changes in gradient echo T2*-weighted magnet resonance imaging (T2* MRI) increases with the field strength and should increase the sensitivity for detection of cerebral microbleeds (CMBs) at 3.0 T. To test these hypotheses, we prospectively examined individuals with documented CMBs at 1.5 and 3.0 T.
Materials And Methods: Five hundred fifty elderly individuals, who participated in an interdisciplinary study of healthy aging, were examined at 3.0 T using T2* MRI sequences (repetition time [TR]/echo time [TE]/flip angle [FA] = 573 ms/16 ms/18 degrees ). Individuals positive for CMBs were asked to undergo an additional examination at 1.5 T (TR/TE/FA = 663 ms/23 ms/18 degrees ). Images were analyzed independently by two observers. CMBs were counted throughout the brain and were qualitatively analyzed comparing the degree of visible hypointensity on a 5-point scale from 1 (complete signal loss) to 5 (no detection) for both field strengths. Contrast-to-noise ratio of CMBs to surrounding brain tissue was calculated.
Results: At 3.0 T, CMBs were detected in 45 of 550 individuals; 25 agreed to an additional examination at 1.5 T. In this group (n = 25), a total of 53 CMBs were detected at 3.0 T, compared to 41 CMBs at 1.5 T. The mean contrast-to-noise ratio of CMBs was significantly increased at 3.0 T compared to 1.5 T (27.4 +/- 8.2 vs. 17.4 +/- 8.0; p < .001). On qualitative analysis, visibility of CMBs was ranked significantly higher at 3.0 T (1.3 +/- 0.4 vs. 2.9 +/- 1.1; p < .001).
Conclusion: Evidence of past microbleeds may even be found in neurologically normal elderly individuals by MRI. Detection rate and visibility of CMBs benefit from the higher field strength, resulting in a significantly improved depiction of iron-containing brain structures (CMBs) at 3.0 T with potential clinical relevance.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.acra.2008.01.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Study Objectives: Sleep deficiency is associated with Alzheimer's disease (AD) pathogenesis. We examined the association of sleep architecture with anatomical features observed in AD: (1) atrophy of hippocampus, entorhinal, inferior parietal, parahippocampal, precuneus, and cuneus regions ("AD-vulnerable regions") and (2) cerebral microbleeds.
Methods: In 271 participants of the Atherosclerosis Risk in the Communities Study, we examined the association of baseline sleep architecture with anatomical features identified on brain MRI 13∼17 years later.
Characterizing the underlying microangiopathy of deep cerebellar intracerebral hemorrhage.
J Neurol
January 2025
Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Introduction: While cerebral amyloid angiopathy is likely responsible for intracerebral hemorrhage (ICH) occurring in superficial (grey matter, vermis) cerebellar locations, it is unclear whether hypertensive arteriopathy (HA), the other major cerebral small vessel disease (cSVD), is associated with cerebellar ICH (cICH) in deep (white matter, deep nuclei, cerebellar peduncle) regions. We tested the hypothesis that HA-associated neuroimaging markers are significantly associated with deep cICH compared to superficial cICH.
Patients And Methods: Brain MRI scans from consecutive non-traumatic cICH patients admitted to a referral center were analyzed for cSVD markers.
Retinal vasculature changes as indicators of imaging signs of cerebral small vessel disease: A community-based, cross-sectional study of older adults.
J Clin Neurosci
January 2025
Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, China. Electronic address:
Objectives: This study investigated the correlation between retinal vasculature and cerebral small vessel disease (CSVD) imaging markers, providing new evidence for the retina-brain association.
Methods: Two hundred and thirty-nine participants aged 55-85 were enrolled in the study. CSVD indicators, encompassing white matter hyperintensities (WMHs), lacunes (LAs), cerebral microbleeds (CMBs), and enlarged perivascular spaces (EPVSs), were assessed.
Cerebral Microbleeds and Amyloid Pathology Estimates From the Amyloid Biomarker Study.
JAMA Netw Open
January 2025
Alzheimer Center Limburg, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.
Importance: Baseline cerebral microbleeds (CMBs) and APOE ε4 allele copy number are important risk factors for amyloid-related imaging abnormalities in patients with Alzheimer disease (AD) receiving therapies to lower amyloid-β plaque levels.
Objective: To provide prevalence estimates of any, no more than 4, or fewer than 2 CMBs in association with amyloid status, APOE ε4 copy number, and age.
Design, Setting, And Participants: This cross-sectional study used data included in the Amyloid Biomarker Study data pooling initiative (January 1, 2012, to the present [data collection is ongoing]).
Development and validation of a clinical features-based nomogram for predicting neonatal cerebral microbleeds.
Quant Imaging Med Surg
January 2025
Department of Radiology, The First Hospital of Tsinghua University, Beijing, China.
Background: Neonatal cerebral microbleeds (CMBs) occur infrequently, and during the initial phase, they often present without noticeable clinical symptoms, which can result in delays in both diagnosis and treatment. There has been relatively little research conducted on neonatal CMBs, with even less focus on their related risk factors. However, identifying risk factors and proactively preventing microbleeds is particularly crucial for effective treatment.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!